SemaglutideRx
GLP-1 Receptor Agonist

SemaglutideRx
GLP-1 Receptor Agonist
TirzepatideRx
Dual GLP-1 + GIP Receptor Agonist
Semaglutide ODT PillsRx
GLP-1 Receptor Agonist - Oral Dissolving Tablet
Tirzepatide ODT PillsRx
Dual GLP-1 + GIP Receptor Agonist - Oral Dissolving Tablet
Men's Complete Hair Growth PillRx
Minoxidil, Finasteride, Biotin
Men's Advanced Hair SprayRx
Minoxidil, Finasteride, Fluocinolone, Tretinoin
Women's Premium Hair SprayRx
Minoxidil, Tretinoin, Fluocinolone, Biotin, Melatonin
Women's Complete Hair Growth PillRx
Minoxidil, Vitamin E, Biotin
Written by Join Luma Team
November 8, 2026 · 8 min read

During your first two weeks on a GLP-1, appetite changes, early fullness, nausea, constipation or fatigue can occur, but some people notice little change.
Mild symptoms can often be discussed with your clinician; severe abdominal pain, persistent vomiting, dehydration or an allergic reaction require urgent medical attention.
You may become satisfied with a smaller meal, lose interest in snacks, or notice that food sits heavily if you eat your usual portion. Others feel much the same during the first weeks. The timing and intensity of appetite effects differ, so neither a dramatic response nor an uneventful first dose is required for treatment to be on track.
GLP-1 medicines influence appetite and delay stomach emptying. That can make eating past comfortable fullness unpleasant. Start with a smaller serving and leave yourself permission to have more if you remain hungry. Your early goal is learning your response while staying nourished, not seeing how little food you can tolerate. See what to expect from your first injection for preparation tips.
The starting dose is a tolerability step: it introduces the medication gradually rather than trying to reach a maintenance dose immediately. The FDA-approved Wegovy and Zepbound labels use gradual dose escalation to reduce gastrointestinal reactions. Those brand schedules are references, not a personalized Join Luma schedule.
Stay with the dose on your prescription until your Join Luma clinician directs otherwise. Feeling hungry in week two is not permission to take an extra dose, and nausea is not a reason to design your own smaller dose. Tell the care team what you are experiencing so it can decide whether any adjustment is appropriate. The Zepbound prescribing information and Instructions for Use states:
“The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage.”
| Experience | Useful next step |
|---|---|
| Mild nausea or early fullness | Try smaller meals and record triggers; contact the clinician if persistent. |
| Constipation | Review fluid intake, gradually increase tolerated fiber and stay active. |
| Fatigue | Check whether you are eating and drinking enough; report ongoing or marked fatigue. |
| Persistent vomiting or severe pain | Seek urgent care, not routine reassurance. |
Nausea, vomiting, diarrhea, constipation and fatigue are reported in FDA-approved product labeling, but not everyone experiences them. Symptoms that are manageable initially can become a problem if they interfere with drinking, eating or daily activity. You do not need to wait until a scheduled follow-up to ask for help. The Wegovy prescribing information and Medication Guide describes gastrointestinal adverse reactions and dehydration-related kidney risk.
Build modest meals around foods you can tolerate. Try a small serving of protein, a starch such as toast or rice, and fruit or vegetables as tolerated. Eat slowly, pause during the meal, and stop before uncomfortable fullness. Very rich meals, large portions and eating quickly may be less comfortable while you are adjusting.
The protein calculator can support meal planning, but a clinician or dietitian can tailor a target to your medical needs. The aim is consistent nutrition, not a rigid menu or forcing yourself to finish a large plate.
Smaller food intake and changes in routine can affect bowel habits. Increase fiber gradually rather than adding a large amount overnight, drink adequate fluids if medically appropriate, and keep moving with short walks or other comfortable activity. The Treatment for Constipation recommends fluids, fiber and activity as part of constipation treatment.
Ask your clinician before starting a laxative, especially if constipation is new, persistent or accompanied by pain. Severe abdominal pain, vomiting, a swollen abdomen or inability to pass gas needs prompt assessment rather than repeated home remedies. Track bowel movements so the care team can distinguish a mild change from a worsening pattern.
For fatigue, check practical basics: have you skipped several meals, slept poorly or cut fluids because of nausea? These are useful clues, not a diagnosis. Marked weakness, fainting or dehydration needs urgent care. Persistent tiredness deserves clinician review even if you suspect the medication is involved.
Keep a short log of dose time, injection site, appetite, meals, fluid intake, bowel movements and any symptoms. Write down severity and duration rather than just “felt bad.” For example, knowing whether nausea lasted an hour after dinner or prevented drinking all day changes the clinical conversation.
Avoid judging success from a single weigh-in. Fluid balance, constipation and ordinary day-to-day variation can obscure a trend. Check your prescription before the next dose, and use the missed-dose guide only as a brand-label reference if your schedule is disrupted. Join Luma support is available through the portal or support@joinluma.com for non-emergency questions.
Seek urgent care for severe or persistent abdominal pain, especially pain that spreads to your back, persistent vomiting, inability to keep fluids down, or signs of dehydration such as very little urine or marked dizziness. These are not symptoms to simply push through until your next appointment. Severe stomach pain can signal pancreatitis or another condition needing prompt assessment.
Call 911 for trouble breathing, swelling of the face, lips, tongue or throat, fainting, or other signs of a severe allergic reaction. Do not take another dose while a serious medication reaction is being assessed. If you use insulin or a sulfonylurea, ask your clinician about low blood sugar and follow your existing treatment plan for it. The Wegovy prescribing information and Medication Guide and Zepbound prescribing information and Instructions for Use describe these precautions.
Your prescription label and Join Luma clinician’s directions take priority over general information about brand-name products. Compounded semaglutide and compounded tirzepatide are not FDA-approved. FDA-approved brand labels provide useful reference information, but their devices, concentrations, storage allowances and study results do not automatically apply to a compounded prescription.
The Understanding the Risks of Compounded Drugs explains this distinction. Keep the pharmacy label available when asking a question: it identifies the medication, concentration, directions and beyond-use date. A photograph of that label and the supplied syringe can help the care team resolve a measurement question without guessing. Never use someone else’s dose or syringe marking as your own instructions.
Same price every dose
A licensed provider reviews your intake. If treatment is appropriate, your medication ships free with expedited two-day delivery.
Get startedCompounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality before marketing. Brand-product study results describe the FDA-approved products studied. A licensed clinician decides whether treatment is appropriate; follow your prescription label and your clinician's directions.
This article is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Individual treatment decisions should be made with a licensed healthcare provider.
Some people notice little change during the first two weeks. Continue only the prescribed dose and discuss your response with your Join Luma clinician rather than increasing it yourself.
No. Nausea is a side effect, not a measure of treatment success, and you do not need to feel sick for treatment to help.
Regular, manageable meals can help maintain nutrition when appetite is reduced. If you cannot eat or drink adequately, contact your clinician; dehydration or persistent vomiting requires urgent care.
There is no guaranteed two-week deadline. Tell your clinician about symptoms that persist, worsen or interfere with eating, drinking or daily life.
Do not increase early unless your Join Luma clinician specifically directs it. Gradual initiation is intended to improve tolerability.
Share this article